Name: Biotechnology and Drug Development for Targeting Human Diseases (en Inglés)
Price: 1462.54 MXN
Availability: InStock
Author: Quiroz, Israel Valencia
ISBN: 9789815223187

Envío gratis

portada Biotechnology and Drug Development for Targeting Human Diseases (en Inglés)

Formato

Libro Físico

Autor

Israel Valencia Quiroz

Editorial

Bentham Science Publishers

Idioma

Inglés

N° páginas

234

Encuadernación

Tapa Blanda

Dimensiones

25.4 x 17.8 x 1.5 cm

Peso

0.57 kg.

ISBN13

9789815223187

Categorías

Biotecnología

Biotechnology and Drug Development for Targeting Human Diseases (en Inglés)

Israel Valencia Quiroz (Autor) · Bentham Science Publishers · Tapa Blanda

Libro Nuevo

$ 1,462.54

$ 2,437.56

Ahorras: $ 975.03

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 29 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Biotechnology and Drug Development for Targeting Human Diseases (en Inglés)"

Biotechnology and Drug Development for Targeting Human Diseases is an insightful compendium on drug development technologies for professionals and students in biotechnology and pharmacology. This book meticulously explores the intersection of biotechnology with drug development, emphasizing its crucial role in creating new therapies for human disease. Central to the book is the innovative use of biotechnology in understanding and treating diseases. It begins with an exploration of multi-omics profiles, shedding light on disease mechanisms and drug development. Subsequent chapters explain in silico methods for drug design, the role of natural products in antimicrobial applications and wound healing, and the use of viruses as carriers in biotechnology. Key features of this reference include a blend of theoretical knowledge and practical insights, detailed analyses of molecular docking in drug discovery, the repurposing of drugs for various diseases, and the emerging field of omics technologies in drug interaction studies. Each chapter is comprehensive, offering current information backed by extensive references, making the book both a foundational and advanced resource.